<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00362089</url>
  </required_header>
  <id_info>
    <org_study_id>EKFZ001_CN</org_study_id>
    <secondary_id>INFAT</secondary_id>
    <nct_id>NCT00362089</nct_id>
  </id_info>
  <brief_title>Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns</brief_title>
  <official_title>The Impact of the Nutritional Fatty Acids During Pregnancy and Lactation for Early Human Adipose Tissue Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Else Kröner-Fresenius-Foundation; International Unilever-Foundation; Danone Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>EU funding by EARNEST consortium;German Ministry of Education and Research GF-GFGI01120708)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregnant and lactating women receive n-3 fatty acids starting from week 15 of gestation until
      4 months post-partum (pp) in comparison to a control group, who only gets information about
      adequately healthy nutrition during pregnancy and lactation.

      The amount of fat in newborns is measured through skinfold thickness, ultrasound, and
      magnetic resonance imaging (MRI).

      It is hypothesised that a reduction in arachidonic acid intake and an increase of n-3 LC
      PUFAs (long chain polyunsaturated fatty acids) via supplements containing docosahexaenoic
      acid (DHA) and eicosapentaenoic acid (EPA) could lead to less expansive fat tissue
      development in the first year of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of overweight and obese children and adolescents dramatically increased during
      the last two decades. In Germany every 5th school child is overweight and 4 - 8% of all
      children are obese.

      Recent studies suggest that fatty acids in maternal nutrition may have an impact on the fat
      tissue development during the fetal period.

      Animal studies showed that a reduction in the arachidonic acid intake, a higher intake of n-3
      LC PUFAs (i.e. DHA and EPA) and a resulting lower n-6/n-3 fatty acid ratio in food will cause
      less expansive fat tissue development in the first year of life.

      In vitro studies and personal observations in animal studies also showed that n-6 fatty acids
      (i.e. arachidonic acid) stimulate the differentiation of preadipocytes to adipocytes whereas
      n-3 fatty acids (i.e. DHA and EPA) have the contrary effect.

      The impact of the maternal fatty acid pattern on the early fat tissue development can only be
      clarified in an intervention study.

      Therefore it is planned to recruit 204 pregnant women in the 14th week of gestation. They
      will be randomly assigned to the intervention or control group.

      The intervention group will receive n-3 LC-PUFAs (DHA and EPA) as fish oil capsules from the
      15th week of gestation until 4 months pp, the control group will get nutrition counselling
      according to the recommendations of the German Society for Nutrition during the same time
      period. Blood samples of the pregnant and lactating women, umbilical cord blood, placental
      tissue and blood of the newborns will be collected for fatty acid analysis.

      Body fat mass in newborns will be determined from delivery until 4 months pp via skinfold
      measurement, ultrasound, and MRI.

      The hypothesis is that newborns in the group of the &quot;supplemented&quot; mothers will have less
      expansive fat tissue development than children from mothers in the control group.

      This would be an innovative primary preventive approach in a period of increasing prevalence
      of overweight and obese children and adolescents.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amount of fat mass in the offspring</measure>
    <time_frame>at birth, 6 weeks, 4 months, 1 year postpartum</time_frame>
    <description>skinfold thickness measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>amount of fat mass in the offspring</measure>
    <time_frame>at 1,5 years, 2 years, 2.5 years, 3 years, 4 years and 5 years postpartum (follow-up)</time_frame>
    <description>skinfold thickness measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offspring body height</measure>
    <time_frame>at birth, 6 weeks, 4 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 4 years and 5 years postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>head circumference of newborns, infants and children</measure>
    <time_frame>at birth, 6 weeks, 4 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 4 years and 5 years postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood lipids of pregnant and lactating women</measure>
    <time_frame>15th wk gestation, 32nd wk gestation, 6 weeks pp, 4 months pp</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatty acid profile of phospholipids and erythrocyte membrane lipids, fatty acid metabolites</measure>
    <time_frame>15th wk gestation, 32nd wk gestation, birth, 6 wks, 4 months, 1 year, 3 years postpartum</time_frame>
    <description>maternal and offspring blood cells and plasma, placenta, umbilical cord tissue, blood cells and plasma, breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>daily intake of maternal fatty acids</measure>
    <time_frame>15 wks gestation, 32nd wks gestation, 6 wks pp</time_frame>
    <description>7 day dietary records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offspring abdominal subcutaneous and preperitoneal fat</measure>
    <time_frame>6 weeks, 4 months , 1 year , 1.5 years , 2 years, 2.5 years, 3 years, 4 years, 5 years postpartum</time_frame>
    <description>Ultrasonography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offspring fat mass, abdominal fat</measure>
    <time_frame>6 weeks, 4 months, 5 years postpartum</time_frame>
    <description>magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal and offspring gene expression (mRNA, miRNA)</measure>
    <time_frame>15 wk gestation, 32nd wk gestation (maternal), birth, 3 years (offspring)</time_frame>
    <description>placenta, umbilical cord tissue, white blood cells, blood plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal and offspring DNA analysis (SNPs, DNA methylation)</measure>
    <time_frame>15 wk gestation, 32nd wk gestation (maternal), birth, 3 years (offspring)</time_frame>
    <description>placenta, umbilical cord tissue, white blood cells</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>epigenetic analyses (histone modification, DNA methylation)</measure>
    <time_frame>birth</time_frame>
    <description>placenta, umbilical cord tissue, white blood cells</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cytokines, adipokines and hormone analysis</measure>
    <time_frame>15th wk gestation, 32nd wk gestation, 6 wks pp, 4 months pp (maternal), birth, 4 months, 1 year, 3 years postpartum (offspring)</time_frame>
    <description>maternal and offspring blood cells and plasma, placenta, umbilical cord blood cells and plasma, breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>protein analysis, proteomics</measure>
    <time_frame>15th wk gestation, 32nd wk gestation (maternal), birth, 4 months, 1 year, 3 years postpartum (offspring)</time_frame>
    <description>maternal and offspring blood cells and plasma, placenta, umbilical cord blood cells and plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolomics, lipidomics</measure>
    <time_frame>15th wk gestation, 32nd wk gestation (maternal), birth, 4 months, 1 year, 3 years postpartum (offspring)</time_frame>
    <description>maternal and offspring blood cells and plasma, placenta, umbilical cord blood cells and plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>breast milk oligosaccharides</measure>
    <time_frame>6 wks and 4 months postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offspring atopic eczema</measure>
    <time_frame>1.5 years - 5 years postpartum</time_frame>
    <description>parent questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offspring allergic diseases (asthma, rhinitis)</measure>
    <time_frame>5 years postpartum</time_frame>
    <description>parent questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>developmental evaluation of children</measure>
    <time_frame>2 years - 5 years postpartum</time_frame>
    <description>parent questionnaire (based on Minnesota Scales)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>motor development of children</measure>
    <time_frame>4 years and 5 years postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity of children</measure>
    <time_frame>2 years - 5 years postpartum</time_frame>
    <description>parent questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary intake of children</measure>
    <time_frame>2 years - 5 years postpartum</time_frame>
    <description>3 day dietary record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offspring body weight</measure>
    <time_frame>at birth, 6 weeks, 4 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 4 years and 5 years postpartum</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">208</enrollment>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Marinol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention group with Marinol D40 fish oil capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutrition counseling</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Marinol D-40</intervention_name>
    <description>Marinol D-40, three capsules per day, from 15th week of gestation until 4th month of lactation</description>
    <arm_group_label>Marinol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age &lt;= 15th week of gestation

          -  Age: 18-43 years

          -  Written informed consent

          -  Body mass index (BMI) before pregnancy between 18 and 30 km/m2

        Exclusion Criteria:

          -  High risk pregnancy

          -  Hypertonus

          -  Chronic diseases (i.e. diabetes mellitus)

          -  Psychiatric diseases

          -  Former supplementation with LC-PUFA
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Hauner, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Technische Universität München</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Technische Universität München</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hauner H, Vollhardt C, Schneider KT, Zimmermann A, Schuster T, Amann-Gassner U. The impact of nutritional fatty acids during pregnancy and lactation on early human adipose tissue development. Rationale and design of the INFAT study. Ann Nutr Metab. 2009;54(2):97-103. doi: 10.1159/000209267. Epub 2009 Mar 19.</citation>
    <PMID>19295192</PMID>
  </reference>
  <reference>
    <citation>Much D, Brunner S, Vollhardt C, Schmid D, Sedlmeier EM, Brüderl M, Heimberg E, Bartke N, Boehm G, Bader BL, Amann-Gassner U, Hauner H. Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age. Eur J Clin Nutr. 2013 Mar;67(3):282-8. doi: 10.1038/ejcn.2013.2. Epub 2013 Jan 23.</citation>
    <PMID>23340492</PMID>
  </reference>
  <reference>
    <citation>Brunner S, Schmid D, Hüttinger K, Much D, Brüderl M, Sedlmeier EM, Kratzsch J, Amann-Gassnerl U, Bader BL, Hauner H. Effect of reducing the n-6/n-3 fatty acid ratio on the maternal and fetal leptin axis in relation to infant body composition. Obesity (Silver Spring). 2014 Jan;22(1):217-24. doi: 10.1002/oby.20481. Epub 2013 Sep 10.</citation>
    <PMID>23596009</PMID>
  </reference>
  <reference>
    <citation>Much D, Brunner S, Vollhardt C, Schmid D, Sedlmeier EM, Brüderl M, Heimberg E, Bartke N, Boehm G, Bader BL, Amann-Gassner U, Hauner H. Breast milk fatty acid profile in relation to infant growth and body composition: results from the INFAT study. Pediatr Res. 2013 Aug;74(2):230-7. doi: 10.1038/pr.2013.82. Epub 2013 May 28.</citation>
    <PMID>23715519</PMID>
  </reference>
  <reference>
    <citation>Brunner S, Schmid D, Hüttinger K, Much D, Heimberg E, Sedlmeier EM, Brüderl M, Kratzsch J, Bader BL, Amann-Gassner U, Hauner H. Maternal insulin resistance, triglycerides and cord blood insulin in relation to post-natal weight trajectories and body composition in the offspring up to 2 years. Diabet Med. 2013 Dec;30(12):1500-7. doi: 10.1111/dme.12298. Epub 2013 Sep 11.</citation>
    <PMID>23909286</PMID>
  </reference>
  <results_reference>
    <citation>Hauner H, Much D, Vollhardt C, Brunner S, Schmid D, Sedlmeier EM, Heimberg E, Schuster T, Zimmermann A, Schneider KT, Bader BL, Amann-Gassner U. Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: an open-label randomized controlled trial. Am J Clin Nutr. 2012 Feb;95(2):383-94. doi: 10.3945/ajcn.111.022590. Epub 2011 Dec 28.</citation>
    <PMID>22205307</PMID>
  </results_reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2006</study_first_submitted>
  <study_first_submitted_qc>August 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2006</study_first_posted>
  <last_update_submitted>February 3, 2014</last_update_submitted>
  <last_update_submitted_qc>February 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technische Universität München</investigator_affiliation>
    <investigator_full_name>Ulrike Amann-Gassner</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>n-3 fatty acids</keyword>
  <keyword>n-6 fatty acids</keyword>
  <keyword>long chain polyunsaturated fatty acids</keyword>
  <keyword>pregnancy</keyword>
  <keyword>lactation</keyword>
  <keyword>breast feeding</keyword>
  <keyword>breast milk</keyword>
  <keyword>adipose tissue</keyword>
  <keyword>newborn</keyword>
  <keyword>fetal development</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dronabinol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

